Opsonin Pharma Limited, one of the country’s leading pharmaceutical manufacturers, held its Annual Sales Conference 2026 on Thursday at the International Convention Centre, Bashundhara.

The company has recorded consistent and notable sales growth over the past several years and maintained this momentum throughout 2025, said a press release on Thursday.

According to the IMS Report for the second quarter of 2025, Opsonin Pharma currently ranks among the top-performing pharmaceutical companies in terms of sales in Bangladesh.

Alongside meeting domestic market demand, the company has also been expanding its international presence by exporting pharmaceutical products to a number of countries worldwide.

The conference was attended by all field-level officials of the company. Among the distinguished participants were Opsonin Pharma Chairman Captain (Retd) Abdus Sabur Khan, Managing Director Abdur Rauf Khan, Deputy Managing Director Abdur Rakib Khan, Director (Sales and Marketing) Md Abdul Momen Talukdar, Assistant General Managers (Sales) Md Mahmudul Haque and Debojite Chandra Bhowmick, and Assistant General Managers (PMD) Taj Md Aga Menon and Md Akhtar Hossain, along with other senior officials.

During the programme, Director (Sales and Marketing) Md Abdul Momen Talukdar presented an overview of the current pharmaceutical market scenario, highlighting marketing strategies and the company’s future vision.

He also outlined Opsonin Pharma’s goals, objectives and strategic policy directions aimed at ensuring sustainable growth and further strengthening its leadership position in the market.